Literature DB >> 16225025

Diverticular disease: diagnosis and treatment.

Holly Salzman1, Dustin Lillie.   

Abstract

Diverticular disease refers to symptomatic and asymptomatic disease with an underlying pathology of colonic diverticula. Predisposing factors for the formation of diverticula include a low-fiber diet and physical inactivity. Approximately 85 percent of patients with diverticula are believed to remain asymptomatic. Symptomatic disease without inflammation is a diagnosis of exclusion requiring colonoscopy because imaging studies cannot discern the significance of diverticula. Fiber supplementation may prevent progression to symptomatic disease or improve symptoms in patients without inflammation. Computed tomography is recommended for diagnosis when inflammation is present. Antibiotic therapy aimed at anaerobes and gram-negative rods is first-line treatment for diverticulitis. Whether treatment is administered on an inpatient or outpatient basis is determined by the clinical status of the patient and his or her ability to tolerate oral intake. Surgical consultation is indicated for disease that does not respond to medical management or for repeated attacks that may be less likely to respond to medical therapy and have a higher mortality rate. Prompt surgical consultation also should be obtained when there is evidence of abscess formation, fistula formation, obstruction, or free perforation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16225025

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  25 in total

1.  Cecum cancer underlying appendicular abscess. Case report and review of literature.

Authors:  Irene Fiume; Vincenzo Napolitano; Gianmattia Del Genio; Alfredo Allaria; Alberto Del Genio
Journal:  World J Emerg Surg       Date:  2006-04-04       Impact factor: 5.469

2.  Management of right-sided diverticulitis: A retrospective review from a hospital in Japan.

Authors:  Kazuhide Matsushima
Journal:  Surg Today       Date:  2010-03-26       Impact factor: 2.549

3.  Inverse expression of prostaglandin E2-related enzymes highlights differences between diverticulitis and inflammatory bowel disease.

Authors:  Liying Dai; Denis W King; D Shevy Perera; David Z Lubowski; Elizabeth Burcher; Lu Liu
Journal:  Dig Dis Sci       Date:  2015-02-11       Impact factor: 3.199

Review 4.  Expanding applications: the potential usage of 5-aminosalicylic acid in diverticular disease.

Authors:  Antonio Tursi; Raymond E Joseph; Paul Streck
Journal:  Dig Dis Sci       Date:  2011-05-13       Impact factor: 3.199

5.  Diverticular disease: A therapeutic overview.

Authors:  Antonio Tursi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-02-06

Review 6.  Elective colonic resection after acute diverticulitis improves quality of life, intestinal symptoms and functional outcome: experts' perspectives and review of literature.

Authors:  Antonello Forgione; Salman Yousuf Guraya
Journal:  Updates Surg       Date:  2016-03-25

7.  Management of colonic diverticular disease with poorly absorbed antibiotics and other therapies.

Authors:  Federico Sopeña; Angel Lanas
Journal:  Therap Adv Gastroenterol       Date:  2011-11       Impact factor: 4.409

8.  Short-term Intravenous Antibiotic Treatment in Uncomplicated Diverticulitis Does Not Increase the Risk of Recurrence Compared to Long-term Treatment.

Authors:  Cosimo Riccardo Scarpa; Nicolas Christian Buchs; Antoine Poncet; Béatrice Konrad-Mugnier; Pascal Gervaz; Philippe Morel; Frédéric Ris
Journal:  Ann Coloproctol       Date:  2015-04-30

9.  The diagnosis of diverticulitis in outpatients: on what evidence?

Authors:  Erin S O'Connor; Glen Leverson; Gregory Kennedy; Charles P Heise
Journal:  J Gastrointest Surg       Date:  2010-02       Impact factor: 3.452

10.  Diverticulosis and diverticulitis form no risk for polyps and colorectal neoplasia in 4,241 colonoscopies.

Authors:  M M Meurs-Szojda; J S Terhaar sive Droste; D J Kuik; C J J Mulder; R J F Felt-Bersma
Journal:  Int J Colorectal Dis       Date:  2008-07-02       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.